Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Tezacaftor (VX661) is a small molecule that can be used as a corrector of the cystic fibrosis transmembrane conductance regulator (CFTR) gene function.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 34.00 | |
2 mg | In stock | $ 48.00 | |
5 mg | In stock | $ 75.00 | |
10 mg | In stock | $ 125.00 | |
25 mg | In stock | $ 223.00 | |
50 mg | In stock | $ 360.00 | |
100 mg | In stock | $ 531.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 90.00 |
Description | Tezacaftor (VX661) is a small molecule that can be used as a corrector of the cystic fibrosis transmembrane conductance regulator (CFTR) gene function. |
In vivo | The F508del mutation channel can avoid degradation and be transported to the cell membrane under the action of VX-661. |
Synonyms | VX661 |
Molecular Weight | 520.5 |
Formula | C26H27F3N2O6 |
CAS No. | 1152311-62-0 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Ethanol: < 1 mg/mL (insoluble or slightly soluble)
H2O: < 1 mg/mL (insoluble or slightly soluble)
DMSO: 93 mg/mL (178.7 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Tezacaftor 1152311-62-0 Autophagy Membrane transporter/Ion channel CFTR VX661 inhibit Inhibitor Cystic fibrosis transmembrane conductance regulator VX-661 VX 661 inhibitor